BzODZ-EPyr: Difference between revisions
Content deleted Content added
Importing Wikidata short description: "Chemical compound" (Shortdesc helper) |
m Added UNII |
||
| Line 25: | Line 25: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number = |
| CAS_number = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = WSQ49D7D2Q |
|||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
||
Revision as of 14:36, 7 September 2022
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H24N4O |
| Molar mass | 372.472 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia.[1]
It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does generally not lead to activity loss.[2][3]
See also
References
- ^ Shevyrin V, Melkozerov V, Eltsov O, Shafran Y, Morzherin Y (February 2016). "Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances". Forensic Science International. 259: 95–100. doi:10.1016/j.forsciint.2015.12.019. PMID 26771874.
- ^ Moloney GP, Angus JA, Robertson AD, Stoermer MJ, Robinson M, Wright CE, et al. (March 2008). "Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor". European Journal of Medicinal Chemistry. 43 (3): 513–39. doi:10.1016/j.ejmech.2007.04.007. PMID 17582659.
- ^ US 6930118, Moloney PG, Robertson AD, "3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives", issued 2005, assigned to Amrad Operations Pty. Ltd.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |